Variations in Medicaid Payment Rates for Radiation Oncology.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
01 07 2019
Historique:
received: 03 01 2019
revised: 30 01 2019
accepted: 11 02 2019
pubmed: 5 4 2019
medline: 30 11 2019
entrez: 5 4 2019
Statut: ppublish

Résumé

Interstate variations in Medicaid reimbursements can be significant, and patients who live in states with low Medicaid reimbursements tend to have worse access to care. This analysis describes the extent of variations in Medicaid reimbursements for radiation oncology services across the United States. The Current Procedural Terminology codes billed for a course of whole breast radiation were identified for this study. Publicly available fee schedules were queried for all 50 states and Washington, DC, to determine the reimbursement for each service and the total reimbursement for the entire episode of care. The degree of interstate payment variation was quantified by computing the range, mean, standard deviation, and coefficient of variation. The cost of care for the entire episode of treatment was compared to the publicly available Kaiser Family Foundation (KFF) Medicaid-to-Medicare fee index to determine if the pattern of payment variation in medical services generally is predictive of the variation seen in radiation oncology specifically. Data were available for 48 states and Washington, DC. The total episode reimbursement (excluding image guidance for respiratory tracking) varied from $2945 to $15,218 (mean, $7233; standard deviation, $2248 or 31%). The correlation coefficient of the KFF index to the calculated entire episode of care for each state was 0.55. There is considerable variability in coverage and payments rates for radiation oncology services under Medicaid, and these variations track modestly with broader medical fees based on the KFF index. These variations may have implications for access to radiation oncology services that warrant further study.

Identifiants

pubmed: 30944071
pii: S0360-3016(19)30257-3
doi: 10.1016/j.ijrobp.2019.02.031
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

488-493

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Ankit Agarwal (A)

Department of Radiation Oncology, the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Electronic address: aagarwal@bu.edu.

Jessica Peterson (J)

Independent researcher.

Lesley M Hoyle (LM)

Department of Radiation Oncology, the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Lawrence B Marks (LB)

Department of Radiation Oncology, the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH